Healthcare products company Johnson & Johnson (NYSE:JNJ) on Monday announced an investment of more than USD1bn to strengthen its Vision operations in Jacksonville, Florida, expanding US-based manufacturing, packaging, and distribution capacity.

The investment includes a new state-of-the-art distribution facility and advanced manufacturing and packaging technologies designed to scale operations and support demand for ACUVUE-brand contact lenses, serving more than 40 million patients.

This initiative is part of the company's broader USD55bn US investment programme in manufacturing, research and development, and technology through early 2029.

Construction of the new facility is already underway and is targeted for completion in 2028.

Johnson & Johnson said the expansion builds on more than 40 years of operations in Florida, supporting 3,500 Jacksonville employees and reinforcing its estimated USD6bn annual economic impact in the state.